Slynd: does a drospirenone progestogen-only pill offer an advantage? 25 March 2024
MHRA issues two updates on fluoroquinolone safety 30 January 2024
Semaglutide: a new drug for the treatment of obesity Joel Lexchin, Barbara Mintzes
29 November 2023
Tramadol-warfarin interaction 28 February 2024
Cytisine for smoking cessation 25 April 2024
Managing COPD exacerbations in primary care Anna Moore, Hannah Hylton, Alex Long, Irem Patel
1 July 2024
Safety warning: combination products containing codeine and ibuprofen 18 October 2023
Recent updates from the BNF (BNF 87) 25 April 2024
Safety update: methotrexate and photosensitivity reactions 29 November 2023
Safety update: omega-3-acid ethyl esters and atrial fibrillation 28 February 2024
ADHD medication shortages: more than just a supply issue Alexandra Lewis, Teck K Khong
30 January 2024
Managing hypertension in older people: current concepts James Steckelmacher, Catherine Graham, Carmela Maniero, Ajay Gupta
25 September 2024
Challenging use of psychotropic medication in young people David Branford, Anne Webster, David Gill, Teresa Randon, Kirsten Peebles
29 July 2024
Managing acne vulgaris: an update Miriam Santer, Esther Burden-Teh, Jane Ravenscroft
27 December 2023
▼Fezolinetant for menopausal vasomotor symptoms 29 July 2024
▼Ritlecitinib for severe alopecia areata 29 May 2024
Introduction to pharmacogenetics John Henry McDermott, William Newman
24 October 2023
Donanemab in early symptomatic Alzheimer’s disease 25 April 2024
MHRA issues further update on fluoroquinolone safety 29 May 2024
▼Icosapent ethyl for CV risk reduction 6 September 2024
